Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases
Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen…